THE ONLY NON-INVASIVE SOLUTION THAT OPENS A TRUE AND CLEAR WINDOW TO THE PATIENT’S HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
NICaS is an easy to use, non-invasive, actionable, robust & cost effective system for the challenging task of treatment and monitoring of hemodynamic and fluid management problems.
OUR VISION
We strive to provide non-invasive solutions to the various challenges in the cardiovascular field from Hypertension, CHF, Haemodialysis, ICU/CCU, Neonatal & the treatment of infectious diseases
“To provide the much needed solution for non invasive hemodynamic and fluid management in both inpatient and outpatient settings”
Flexible platform, enabling integration to various settings, (Monitor, laptop, tablet & Mobile). Ability to operate as a standalone system or be integrate/OEM into existing client’s systems. The NICaS is the only known system to enable true flexibility per Client’s existing computer infrastructure.
OUR SOLUTIONS
Stroke Volume and Cardiac Output are basic vital signs that enables the treating physician to better treat and monitor their patients in a wide array of clinical applications.
As the traditional methods to measure these parameters require invasive procedure such as the insertion of a catheter and therefore the use of of these parameters are limited.
Our Non Invasive technology, enable physicians, whenever they are, to measure these parameters in a variety of settings hospital, clinic, patient home)
This will lead to improved medical outcomes, both chronically and acutely, in a wide clinical applications including: Heart Failure management, Hypertension control, Hemodialysis, Preeclampsia, CRT optimization, Hemodynamic management during anesthesia and more.
CLINICAL APPLICATION
THE CHALLENGE
OUR SOLUTION
HEART FAILURE
Average readmission rate
for Patinet with HF is 30%
Using NICaS for management of HF patients reduces Hospital
Readmission rate by over 90%
HYPERTENSION
Only 50% of Hypertensive patients in the US are
under control
Customers who are
using NICaS for
hypertension control
report 93% control rate
Preeclampsia
Preeclampsia and eclampsia progresses rapidly and are associated with increased risk of significant maternal and perinatal adverse outcomes, including placental abruption, preterm birth, and low birthweight.
NICaS Hemodynamic NAVIGATOR System which is designed to assist physicians to find the exact cause of hypertension based on patient’s objective hemodynamic parameters.
DIALYSIS
Although crucial for proper treatment Patients Dry weight and Hemodynamic profile are estimated rather measured, resulting in sub optimal treatment and high percentage of hospitalisations
NICaS can provide each
patient hemodynamic
profile allowing to set
more accurate dry weight
and treatment strategy
and thus reduce the
amount of unnecessary
hospitalizations
ICU/ICCU
While Hemodynamic Information is crucial for Patient management in the ICU only this data is only available for 20-30%
NICaS NavigatorTM
provides safe accurate
and continuous info
regarding patients
Cardio respiratory profile
COVID 19
Due to the pandemic many healthcare systems are being overwhelmed and are unable to provide optimal respiratory treatment to their patients, in addition over 20% of COVID 19 patients develop cardiac injury (this is in addition to the patient with pre-existing cardiac conditions)
NICaS can provide an
accurate continuous
cardiorespiratory
information to optimise
the treatment for patient
with ARDS, while limiting
the exposure of medical
team and thus risk of
infection
Pharma Clinical trials
Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety, due to the high cost and reproducibility limitation of the current methods such as Echocardiography and Thermodilution
NICaS provides cost
effective easy to use
highly accurate,
sensitive and reproducible
hemodynamic
information allowing
to speed up the drug
development process
NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:
CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME
EASY SETUP
NICaS can connect to any device such as tablet, laptop or desk top computer with an easy and quick installation process.
SIMPLE OPERATION
No need to shave or undress the patients .
Only two sensors are required to be patched.
REPORT
Flexible and easy to read enabling the treating physician to prioritize the hemodynamic and fluid parameters.
SOME OF OUR REGULATORY
APPROVALS / CLEARANCES
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.
THE ONLY NON-INVASIVE SOLUTION THAT OPENS A TRUE AND CLEAR WINDOW TO THE PATIENT’S HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
NICaS is an easy to use, non-invasive, actionable, robust & cost effective system for the challenging task of treatment and monitoring of hemodynamic and fluid management problems.
Watch NICaS Intro:
OUR VISION
We strive to provide non-invasive solutions to the various challenges in the cardiovascular field from Hypertension, CHF, Haemodialysis, ICU/CCU, Neonatal & the treatment of infectious diseases “To provide the much needed solution for non invasive hemodynamic and fluid management in both inpatient and outpatient settings” Flexible platform, enabling integration to various settings, (Monitor, laptop, tablet & Mobile). Ability to operate as a standalone system or be integrate/OEM into existing client’s systems. The NICaS is the only known system to enable true flexibility per Client’s existing computer infrastructure.
OUR SOLUTIONS
Stroke Volume and Cardiac Output are basic vital signs that enables the treating physician to better treat and monitor their patients in a wide array of clinical applications.
As the traditional methods to measure these parameters require invasive procedure such as the insertion of a catheter and therefore the use of of these parameters are limited.
Our Non Invasive technology, enable physicians, whenever they are, to measure these parameters in a variety of settings hospital, clinic, patient home)
This will lead to improved medical outcomes, both chronically and acutely, in a wide clinical applications including: Heart Failure management, Hypertension control, Hemodialysis, Preeclampsia, CRT optimization, Hemodynamic management during anesthesia and more.
HEART FAILURE
THE CHALLENGE:
Average readmission rate for
Patient with HF is 30%
OUR SOLUTION:
Using NICaS for management of HF patients reduces Hospital
Readmission rate by over 90%
HYPERTENSION
THE CHALLENGE:
Only 50% of Hypertensive patients
in the US are under control
OUR SOLUTION:
Customers who are using NICaS for hypertension control report93% control rate
Preeclampsia
THE CHALLENGE:
Preeclampsia and eclampsia progresses rapidly and are associated with increased risk of significant maternal and perinatal adverse outcomes, including placental abruption, preterm birth, and low birthweight.
OUR SOLUTION:
NICaS Hemodynamic NAVIGATOR System which is designed to assist physicians to find the exact cause of hypertension based on patient’s objective hemodynamic parameters.
DIALYSIS
THE CHALLENGE:
Although crucial for proper treatment Patients Dry weight and Hemodynamic profile are estimated rather measured, resulting in sub optimal treatment and high percentage of hospitalisations
OUR SOLUTION:
NICaS can provide each patient hemodynamic profile allowing to set more accurate dry weight and treatment strategy and thus reduce the amount of unnecessary hospitalizations
ICU/ICCU
THE CHALLENGE:
While Hemodynamic Information is crucial for Patient management in the ICU only this data is only available for 20-30%
OUR SOLUTION:
NICaS NavigatorTM provides safe accurate and continuous info regarding patients Cardio respiratory profile
COVID 19
THE CHALLENGE:
Due to the pandemic many healthcare systems are being overwhelmed and are unable to provide optimal respiratory treatment to their patients, in addition over 20% of COVID 19 patients develop cardiac injury (this is in addition to the patient with pre-existing cardiac conditions)
OUR SOLUTION:
NICaS can provide an accurate continuous cardiorespiratory information to optimise the treatment for patient with ARDS, while limiting the exposure of medical team and thus risk of infection
Pharma Clinical trials
THE CHALLENGE:
Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety, due to the high cost and reproducibility limitation of the current methods such as Echocardiography and Thermodilution
OUR SOLUTION:
NICaS provides cost effective easy to use highly accurate, sensitive and reproducible hemodynamic information allowing to speed up the drug development process
NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:
CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HUYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME PATIENTS’ HOME
EASY SETUP
NICaS can connect to any device such as tablet, laptop or desk top computer with an easy and quick installation process.
SIMPLE OPERATION
No need to shave or undress the patients. Only two sensors are required to be patched
REPORT
Flexible and easy to read enabling the treating physician to prioritize the hemodynamic and fluid parameters.
SOME OF OUR Regulatory Approvals / Clearances:
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.